Encochleated amphotericin B (Matinas BioPharma)
两性霉素B (Matinas BioPharma)
Report date: 2026/03/12 20:00:16
Base Information
Drug NameEncochleated amphotericin B (Matinas BioPharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAquarius BioTechnologies Inc
China Registration ClassN/A
Develop Information
Active CompaniesMatinas Biopharma Nanotechnologies Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksN/A